Taho Pharmaceuticals Ltd. (TPEX:6467)
144.00
+5.50 (3.97%)
At close: Jan 19, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 7.07 billion as of January 21, 2026. Its market cap has increased by 4,402.61% in one year.
Market Cap
7.07B
Enterprise Value
6.68B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
144.00
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 7.07B, an increase of 238.10%. That is a compound annual growth rate of 11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 7.07B | 23.32% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 45.64T |
| Hon Hai Precision Industry | 3.20T |
| Delta Electronics | 2.91T |
| MediaTek | 2.37T |
| ASE Technology Holding | 1.30T |
| Fubon Financial Holding | 1.30T |
| Cathay Financial Holding | 1.14T |
| Quanta Computer | 1.09T |